Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2003
10/01/2003EP1348704A1 Indole derivatives as 5-HT2C antagonists, process for their preparation and pharmaceutical compositions containing them
10/01/2003EP1348701A1 (2,4-disubstituted-thiazol-5-yl) amine compounds as PDE7 inhibitors
10/01/2003EP1348433A1 Thiazol-2-yl-imine compounds as PDE-7 inhibitors
10/01/2003EP1347990A2 Peptide mit inhibierender aktivität zur produktion von stickstoffmonoxid
10/01/2003EP1347979A1 Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands
10/01/2003EP1347976A2 Tricyclic purine compounds and their analogs as inhibiotrs of cytokine signalling
10/01/2003EP1347971A1 Thiazolyl inhibitors of tec family tyrosine kinases
10/01/2003EP1347968A1 Lfa-1 antagonist compounds
10/01/2003EP1347966A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/01/2003EP1347779A2 Use of a triple combination comprising a 5ht3 antagonist, a 5ht4 agonist and a laxative for promoting intestinal lavage
10/01/2003EP1347762A2 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2)
10/01/2003EP1347761A2 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives
10/01/2003EP1347755A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
10/01/2003EP1347746A1 Over-coated chewing gum formulations including tableted center
10/01/2003EP1206472B1 Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent
10/01/2003EP1202996B1 Titanium derived compounds, preparation and use thereof
10/01/2003EP1202954B1 Novel aminobenzophenones
10/01/2003EP1000029B1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders
10/01/2003EP0977558B1 Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors
10/01/2003EP0772596B1 INDOLIZINE sPLA2 INHIBITORS
10/01/2003EP0662087B1 Method for purifying retinal pigmented epithelium derived neurotrophic factor
10/01/2003CN1446229A Somatostatin analogues
10/01/2003CN1446218A Benzimidazole derivatives, preparation method and therapeutic use thereof
10/01/2003CN1446202A 2-aminopyridine compounds and use thereof as drugs
10/01/2003CN1446201A Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
10/01/2003CN1446193A Aminoadamantane derivatives as therapeutic agents
10/01/2003CN1446103A Treating endotoxemia and related disorders with probiotics
10/01/2003CN1446099A Remedies for chronic hepatitis B
10/01/2003CN1446098A Modulation of alpha-6 integrin-mediated responses
10/01/2003CN1446087A Use of lipase inhibitors
10/01/2003CN1446054A Composition and use
10/01/2003CN1444996A Oral DNA combination for treating chronic infection of hepatitis B virus
10/01/2003CN1444995A Method for filtering out matters possible to restrain and/or activate target biological activity in a iming at phenomena of spatial allosterism of the target
10/01/2003CN1444985A Oil for comforting channels and collaterals
10/01/2003CN1444974A Capsule with high cellulose for expelling of toxin and nourishing skin as well as its manufacturing methods
10/01/2003CN1444973A Application of orostachys in medicine for curing intestinal tract disease and its drug
10/01/2003CN1444960A Method of preparing health products for improving gstrointestinal tract functions
10/01/2003CN1444959A Chinese herbal medicine for birds and beasts use and its preparing method
10/01/2003CN1444957A Beneficial vigor pills
10/01/2003CN1444955A Chinese herbal medicine for treating hepatitis
10/01/2003CN1444953A Health protection wine for improvement of inferior health
10/01/2003CN1444950A Technique for preparing granules of ÔÇÿfrog oilÔÇÖ"
10/01/2003CN1444936A Drop pills of ÔÇÿWurenchunÔÇÖ and its preparing method
10/01/2003CN1444929A Fibrauretine dispersant tablet and its preparing method
10/01/2003CN1444928A Drop pills of five esters and its preparing method
10/01/2003CN1444922A Application of biologically active substance-fenugreek ketone and its derivatives
10/01/2003CN1122670C Thiazolobenzoheterocycles, prepn method and medicines containing same
10/01/2003CN1122662C Arylsulfonylamino hydroxamic acid derivatives
10/01/2003CN1122526C Medicine for treating hepatitis B and preparation method thereof
10/01/2003CN1122525C Medicine for treating gastropathy and preparation process thereof
10/01/2003CN1122516C Medicine for treating oral and throat disease
10/01/2003CN1122509C Medicinal adhesive plastic for treating hepatism
09/2003
09/30/2003US6627754 Pyrrolo[2,3-d]pyrimidine compounds
09/30/2003US6627656 Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore
09/30/2003US6627653 Anticonvulsant derivatives useful for the treatment of depression
09/30/2003US6627649 (2S)-1-((2R,3S)-5-chloro-3-(2-chlorophenyl)-1-(3,4 -dimethoxybenzenesulfonyl)-3-hydroxy-2,3-dihydro-1H-indole-2 -carbonyl)pyrrolidine-2-carboxamide, a selective V1a arginine vasopressin receptor antagonist, in combination with the
09/30/2003US6627644 4-piperidinyl alkyl amine derivatives as muscarinic receptor antagonists
09/30/2003US6627637 I kappa B kinase inhibitors for treating various disorders including arthritis
09/30/2003US6627628 Cardiovascular diseases such as hypertension, angina pectoris, heart failure, thrombosis and atherosclerosis. The compounds of formula (I) are able to modulate the body's own production of cyclic guanosine monophosphate (cGMP) and are suitable for
09/30/2003US6627626 Antiinflammation agents and antiarthritic agents colon cancer, and Alzheimer's disease in mammals, preferably humans, dogs, cats and livestock animals.
09/30/2003US6627615 Methods and compositions for in vivo gene therapy
09/30/2003US6627602 Preventing desensitization of receptors
09/30/2003US6627224 Low dose entecavir formulation and use
09/30/2003US6627213 Administering on the same day the infant is fed human breast milk a supplement free of carbohydrate and comprising casein, salts of casein, whey, and casein hydrolysates; decrease of jaundice and increase of excretion of bilirubin
09/30/2003US6627195 Binding agents to CD23
09/30/2003CA2406592C Method of preparing pharmaceutical dosage forms containing multiple active ingredients
09/30/2003CA2291974C Composition comprising panax pseudo ginseng and eucommiae ulmoides
09/30/2003CA2254750C Inhibition of matrix metalloproteases by 2-(.omega.-aroylalkyl)-4-biaryl-oxobutyric acids
09/30/2003CA2245768C Methods for treating emesis and central nervous system disorders using optically pure (+) norcisapride
09/30/2003CA2106073C Composition for promoting tissue repair and regeneration
09/30/2003CA2102697C Pyrrolidine derivatives, preparation thereof and drugs containing same
09/25/2003WO2003078632A1 Novel receptor polypeptides and polynucleotides encoding the same
09/25/2003WO2003078614A2 Gntiii (udp-n-acethylglucosamine:beta-d mannoside beta (1,4)-n-acethylglucosaminy ltransferase iii) expression in plants
09/25/2003WO2003078609A1 Methods of inducing differentiation of stem cells into a specific cell lineage
09/25/2003WO2003078608A1 Methods of inducing differentiation of stem cells into a specific cell lineage
09/25/2003WO2003078588A2 Primitive and proximal hepatic stem cells
09/25/2003WO2003078568A2 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
09/25/2003WO2003078469A1 Anti-human hepatoma monoclonal antibody hab18 light/heavy chain variable region gene, and use thereof
09/25/2003WO2003078435A1 Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
09/25/2003WO2003078428A1 Difurylglycolic acid tropenol esters used as anticholinesterase drugs
09/25/2003WO2003078425A1 Novel crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt
09/25/2003WO2003078422A1 Novel pyridone derivative
09/25/2003WO2003078421A1 Piperidine derivatives useful as modulators of chemokine receptor activity
09/25/2003WO2003078413A1 Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity
09/25/2003WO2003078409A1 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient
09/25/2003WO2003078404A1 Pyrimidine derivatives
09/25/2003WO2003078395A1 Piperidine derivatives useful as modulators of chemokine receptor activity
09/25/2003WO2003078376A1 Nk1 antagonists
09/25/2003WO2003077949A2 Methods of treating diabetes using pde 11a inhibitors
09/25/2003WO2003077947A1 Methods of modulating cd200 receptors
09/25/2003WO2003077919A1 Fluorinated 4-azasteroid derivatives as androgen receptor modulators
09/25/2003WO2003077916A1 Use of proton pump inhibitors for the treatment of noncardiac chest pain
09/25/2003WO2003077915A1 Use of rapamycin for inhibiting of cell death
09/25/2003WO2003077914A1 N3 alkylated benzimidazole derivatives as mek inhibitors
09/25/2003WO2003077910A1 Methods of treatment with selective ep4 receptor agonists
09/25/2003WO2003077908A1 Use of selective ep4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension
09/25/2003WO2003077897A1 Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes
09/25/2003WO2003077893A2 Compositions for treating digestive functional pathologies
09/25/2003WO2003077863A2 Method for overexpression of zwitterionic polysaccharides
09/25/2003WO2003077847A2 Substituted amides
1 ... 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 ... 1258